ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

This study has been terminated.
(The development program has been terminated)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00263965
First received: December 9, 2005
Last updated: March 14, 2008
Last verified: March 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given